IQVIA™ Real-World Insights Bibliography

The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease
Author(s): Lars Holger Ehlers 1, Mark Lamotte 2, Sofia Monteiro 3, Susanne Sandgaard 4, Pia Holmgaard 4, Evan C Frary 4, Niels Ejskjaer 5 6 7
Affiliations(s): 1Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 2IQVIA Real World Solutions, Zaventem, Belgium. 3IQVIA Real World Solutions, London, UK. 4Boehringer Ingelheim Danmark A/S, København Ø, Hovedstaden, Denmark. 5Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. n.ejskjaer@rn.dk. 6Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk. 7Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk.
Publication(s):  Diabetes Therapy https://doi.org/10.1007/s13300-021-01040-y
IQVIA HEOR Zaventem Brussels
PMID: 33856655 PMCID: PMC8099952 DOI: 10.1007/s13300-021-01040-y
Document Type(s): 
Countries: Denmark,
Click here for the abstract
C:
Y:
Diabetes, Health economics,
2021
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
Comparison of electronic self-reported prescription medication use during pregnancy with the national prescription register in Denmark
Author(s): Maja Laursen 1, Christine E Hallgreen 2 3, Nancy Dreyer 4, Alison Bourke 5, Shahrul Mt-Isa 2 6, Stella Blackburn 5
Affiliations(s): 1The Danish Health Data Authority, Copenhagen, Denmark. 2School of Public Health, Imperial College London, London, UK. 3Copenhagen Center for Regulatory Science, Department of Pharmacy, SUND, University of Copenhagen, Copenhagen, Denmark. 4IQVIA Real-World and Analytic Solutions, Boston, Massachusetts. 5IQVIA Real-World and Analytic Solutions, London, UK. 6Biostatistics and Research Decision Sciences, MSD Research Laboratories, London, UK.
Publication(s):  Pharmacoepidemiol Drug Saf . 2020 Mar;29(3):328-336. doi: 10.1002/pds.4937. Epub 2019 Dec 6.
Document Type(s): Article,
Countries: Denmark, UK, USA,
Click here for the abstract
C:
Y:
Patient Registries & Real-World Study Methods, Pregnancy,
2020
  L:
A:
English
Epidemiological study, Methodology, Patient questionnaire, Real World Data,
  Add to report
 
 
External Validation of the Core Obesity Model to Assess the Cost Effectiveness of Weight Management Interventions
Author(s): Sandra Lopes 1, Pierre Johansen 2, Mark Lamotte 3, Phil McEwan 4, Anamaria-Vera Olivieri 5, Volker Foos 4
Affiliations(s): 1Novo Nordisk A/S, Søborg, Denmark. snlb@novonordisk.com. 2Novo Nordisk A/S, Søborg, Denmark. 3IQVIA, Zaventem, Belgium. 4Health Economics and Outcomes Research Ltd, Cardiff, UK. 5IQVIA, Basel, Switzerland.
Publication(s):  Pharmacoeconomics 2020 https://doi.org/10.1007/s40273-020-00941-3 + Pharmacoeconomics. 2021 Jan;39(1):137-138. doi: 10.1007/s40273-020-00982-8. Epub 2020 Nov 30
Document Type(s): Article,
Countries: Belgium, Denmark, Switzerland, UK,
Click here for the abstract
C:
Y:
Health economics, Obesity,
2020
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
The Cost-Effectiveness of Empagliflozin in Type 2 Diabetes in Denmark, Incorporating Cardiovascular Outcomes
Author(s): Ehlers LH, Lamotte M, Monteiro S, Sandgaard S, Holmgaard P, Frary EC, Staehr P, Ejskjaer N.
Affiliations(s): IQVIA HEOR Zaventem Brussels
Publication(s):  ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107114
Document Type(s): Poster,
Countries: Denmark,
C:
Y:
Diabetes, Health economics,
2020
  L:
A:
English
Clinical setting: Primary care, Cost effectiveness,
  Add to report
 
 
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Author(s): Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations(s): IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publication(s):  Presented at ISPE?s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24?28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Type(s): Poster,
Countries: Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland,
Click here for the abstract
C:
Y:
Hematology, Oncology,
2019
  L:
A:
English
Public Health, Survey research,
  Add to report
 
 
Assessing the Outcomes for Orphan Status or Accelerated Assessment EMA Approved Medicines: A Comparison of Health Technology Assessment in Denmark, Finland, Norway and Sweden
Author(s): Falla, Edel; Pitcher, Ashley; Acs, Annabel; Heller, Vincent; Zhang, Rongrong
Affiliations(s): IQVIA, Real-World Insights, London, LON, UK IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Solna, AB, Sweden IQVIA, Real-World Insights, Stockholm, Sweden
Publication(s):  ISPOR Europe 2019, November 5, 2019, Copenhagen, Denmark
Document Type(s): Poster,
Countries: Denmark, Finland, Nordic, Norway, Sweden,
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2019
  L:
A:
English
Review,
  Add to report
 
 
Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Author(s): Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations(s): 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publication(s):  ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Type(s): Oral presentation,
Countries: Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
Different patterns of second?line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Author(s): Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW
Affiliations(s): StatFinn & EPID Research, Espoo, Finland
Publication(s):  Endocrinol Diabetes Metab.
Document Type(s): Article,
Countries: Denmark, Finland, Nordic, Norway, Sweden,
Click here for the abstract
C:
Y:
Diabetes,
2018
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe
Author(s): Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA
Affiliations(s): Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA
Publication(s):  34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Type(s): Abstract,
Countries: Denmark, Finland, Germany, Norway, Sweden, UK,
C:
Y:
Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods,
2018
  L:
A:
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review,
  Add to report
 
 
Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation
Author(s): Jensen ML1,2, Jørgensen ME1, Hansen EH2, Aagaard L3, Carstensen B1.
Affiliations(s): 1 Steno Diabetes Center Copenhagen, Gentofte, Denmark. QuintilesIMS 2 Faculty of Health and Medical Sciences, Department of Pharmacy, Section for Social and Clinical Pharmacy, Universitetsparken 2, University of Copenhagen,Denmark. 3 Faculty of Health, University of Southern Denmark, Odense, Denmark.
Publication(s):  PLoS One. 2017; 12(6): e0179546.
Document Type(s): Article,
Countries: Denmark, Nordic,
Click here for the abstract
C:
Y:
Clinical practice, Diabetes,
2017
  L:
A:
English
clinical setting: Secondary care, Compliance, Epidemiological study, Retrospective cohort analysis,
  Add to report
 
 
 1 of 2 Next Page Last Page